Clinical trials
Recruiting Brain Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 2 |
| Bristol-Myers Squibb | 1 |
| Iambic Therapeutics, Inc | 1 |
| InSightec | 1 |
| SWOG Cancer Research Network | 1 |
| Seoul National University Hospital | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 8 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms | 2 |
| Brain Diseases | 1 |
| Breast Diseases | 1 |
| Cardiotoxicity | 1 |
| Central Nervous System Diseases | 1 |
| Central Nervous System Neoplasms | 1 |
| Melanoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.